close 76% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 76% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Dashboard

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

Kodu・Aktsiate loetelu・Moleculin Biotech Inc
Search

Moleculin Biotech Inc

Suletud

1.05 -0.94

Tugev "osta" hinnang

Hinna uuendus 13. mai 2025, 19:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.03

Max

1.07

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+887.96% upside

Moleculin Biotech Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. mai 2025, 23:20 UTC

Tulu

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

DJ

Loe

13. mai 2025, 23:48 UTC

Market Talk

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

DJ

Loe

13. mai 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

13. mai 2025, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

DJ

Loe

13. mai 2025, 23:24 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

DJ

Loe

13. mai 2025, 23:24 UTC

Market Talk
Tulu

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

DJ

Loe

13. mai 2025, 22:58 UTC

Tulu

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

DJ

Loe

13. mai 2025, 22:58 UTC

Tulu

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

DJ

Loe

13. mai 2025, 22:58 UTC

Tulu

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

DJ

Loe

13. mai 2025, 22:58 UTC

Tulu

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

DJ

Loe

13. mai 2025, 22:38 UTC

Tulu

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

DJ

Loe

13. mai 2025, 22:38 UTC

Tulu

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

DJ

Loe

13. mai 2025, 22:37 UTC

Tulu

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

DJ

Loe

13. mai 2025, 22:36 UTC

Tulu

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

DJ

Loe

13. mai 2025, 22:35 UTC

Tulu

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

DJ

Loe

13. mai 2025, 22:34 UTC

Tulu

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

DJ

Loe

13. mai 2025, 22:33 UTC

Tulu

Aristocrat: Interactive Business Delivered Strong Revenue Growth

DJ

Loe

13. mai 2025, 22:33 UTC

Tulu

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

DJ

Loe

13. mai 2025, 22:33 UTC

Tulu

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

DJ

Loe

13. mai 2025, 22:30 UTC

Tulu

Aristocrat Interim Dividend 44 Australian Cents/Share

DJ

Loe

13. mai 2025, 22:30 UTC

Tulu

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

DJ

Loe

13. mai 2025, 22:29 UTC

Tulu

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

DJ

Loe

13. mai 2025, 22:28 UTC

Tulu

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

DJ

Loe

13. mai 2025, 21:15 UTC

Tulu

Nu Holdings 1Q Rev $3.2B >NU

DJ

Loe

13. mai 2025, 21:03 UTC

Peamised uudised

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

DJ

Loe

13. mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

13. mai 2025, 20:32 UTC

Tulu

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

DJ

Loe

13. mai 2025, 20:31 UTC

Tulu

Alcon 1Q Sales $2.45B >ALC.EB

DJ

Loe

13. mai 2025, 20:30 UTC

Tulu

Alcon 1Q Rev $2.47B >ALC.EB

DJ

Loe

13. mai 2025, 20:30 UTC

Tulu

Alcon 1Q EPS 70c >ALC.EB

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Moleculin Biotech Inc Prognoos

Hinnasiht

By TipRanks

887.96% tõus

12 kuu keskmine prognoos

Keskmine 10.67 USD  887.96%

Kõrge 20 USD

Madal 4 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Moleculin Biotech Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Põhineb 3 analüütiku instrumendi Moleculin Biotech Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

747.7

↓-1.07%

JNJ

Johnson and Johnson

148.51

↓-3.47%

UNH

UnitedHealth Group Inc

310.52

↓-17.94%

ABBV

AbbVie Inc

187.96

↓-1.03%

ABT

Abbott Laboratories

129.08

↓-2.23%